The New War Over Generic Drugs
Why are generic drugmakers fighting a plan to let them make more medicines?
Why are generic drugmakers fighting a plan to let them make more medicines?
Plus, a single graph explains Boeing’s crisis, Apple tries to censor its regulator, and Wall Street data debunks the GOP’s anti-ESG crusade.
A new case could decimate state-level consumer protections against predatory banking practices.
The company linked to the Baltimore disaster aims to use a 173-year-old “Titanic Law” to avoid paying big damages — after fossil fuel and other industries lobbied to stop reforms.
Plus, big electric utilities face heat, decarbonization projects take off, feds crack down on corporate misconduct, and Biden’s new judge nominee is blasted for her hedge-fund past.
Maryland’s former governor-turned-Senate candidate championed mega-ships like the one that destroyed the Baltimore bridge.
Corporate interests are funneling far more money to law enforcement than previously known — often with scant oversight.
Regulators cited Maersk for its “illegal policy” blocking employees from reporting safety concerns to the Coast Guard.
Right-wing federal appeal judges signal they support repeal of the no-cost preventive care mandate, all but guaranteeing a Supreme Court showdown.
Plus, immigrants catch a break in some states, environmental regulators combat cancer at its source, and states are taking on the gun lobby.